These pioneering studies indicate that FXTAS, in contrary to the fragile X syndrome, is not due to a reduce expression of FMRP and to a loss of function mechanism, but is more likely caused by an RNA and/or protein gain of function mechanism. This evidence concerns the gene FMR1 and fragile X syndrome.